3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
3
Phase 2
1
Phase 1/2
1
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
20
Pancreatic Neoplasms
19
Carcinoma, Non-Small-Cell Lung
17
Ovarian Neoplasms
16
Fallopian Tube Neoplasms
12
Triple Negative Breast Neoplasms
10
Neoplasm Metastasis
10
Carcinoma, Ovarian Epithelial
10
Unspecified Adult Solid Tumor, Protocol Specific
8
Neoplasms
7
Lung Neoplasms
7
Endometrial Neoplasms
7
Esophageal Neoplasms
6
Brenner Tumor
6
Breast Neoplasms, Male
6
Stomach Neoplasms
5
Melanoma
5
Squamous Cell Carcinoma of Head and Neck
4
Peritoneal Neoplasms
3
Gallbladder Neoplasms
3
Cholangiocarcinoma
3
Adenocarcinoma of Lung
3
Adenocarcinoma
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Salivary Gland Neoplasms
2
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, Non-Hodgkin
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Interventions
Carboplatin
9
pembrolizumab
8
Paclitaxel
8
Cisplatin
8
Radiotherapy, Intensity-Modulated
6
Magnetic Resonance Spectroscopy
6
Gemcitabine
5
fludarabine
4
Specimen Handling
4
Pemetrexed
4
Nivolumab
4
Cyclophosphamide
4
trebananib
3
osimertinib
3
liposomal doxorubicin
3
Radiotherapy
3
Interleukin-2
3
Fluorouracil
3
Docetaxel
3
DNA
3
volociximab
2
poly ICLC
2
lenvatinib
2
fludarabine phosphate
2
Sorafenib
2
Radiosurgery
2
Midazolam
2
Capecitabine
2
Biopsy
2
Bevacizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Carcinoma
×
Taxes
×
Clear all
NCT05494866
2025-03-25
IntenSify
German Cancer Research Center
Phase 1
Terminated
6 enrolled